Clinical trialNCT06411249RecruitingPhase 4Interventional

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

SponsorGlaxoSmithKlineEnrollment350Systemic Lupus Erythematosus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

114 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Berazategui, Argentina
Juan Pablo Vinicki
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Pablo MANNUCCI WALTER
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Andrea Baños
Recruiting
Gsk Investigational Site
Ciudad Autonoma Buenos Aires, Argentina
Patricio Tate
Recruiting
Gsk Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina
Dario Scublinsky
Recruiting
Gsk Investigational Site
La Plata, Argentina
Sebastian Magri
Recruiting
Gsk Investigational Site
Mar del Plata, Argentina
Carolina Iturralde
Recruiting
Gsk Investigational Site
Quilmes, Argentina
Jose Velasco Zamora
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Veronica Ines Bellomio
Recruiting
Gsk Investigational Site
Santa Fe, Argentina
Bernardo Pons Estel
Recruiting

Brazil

Gsk Investigational Site
Belo Horizonte, Brazil
Claudia Neiva
Recruiting
Gsk Investigational Site
Cuiabá, Brazil
Victor Matheus Santos
Recruiting
Gsk Investigational Site
Juiz de Fora, Brazil
Viviane Souza
Recruiting
Gsk Investigational Site
Passo Fundo, Brazil
Alexandre Tognon
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Tatiana Muller
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Cecilia Da Costa
Recruiting
Gsk Investigational Site
Porto Alegre, Brazil
Tamara Mucenic
Recruiting
Gsk Investigational Site
Salvador, Brazil
Gleison Duarte
Recruiting
Gsk Investigational Site
São José do Rio Preto, Brazil
Mariana Martins
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Luciana Seguro
Recruiting
Gsk Investigational Site
São Paulo, Brazil
Karen Hamazaki
Recruiting

France

Gsk Investigational Site
Angers, France
Christian Lavigne
Recruiting
Gsk Investigational Site
Lille, France
eric hachulla
Recruiting
Gsk Investigational Site
Pessac, France
Estibaliz Lazaro
Recruiting
Gsk Investigational Site
Rennes, France
Nicolas Belhomme
Recruiting
Gsk Investigational Site
Saint-Priest-en-Jarez, France
Martin Killian
Recruiting
Gsk Investigational Site
Toulouse, France
Gregory Pugnet
Recruiting

Germany

Gsk Investigational Site
Herne, Germany
Ioana Andreica
Recruiting
Gsk Investigational Site
Lübeck, Germany
Jens Humrich
Recruiting
Gsk Investigational Site
Mainz, Germany
Julia Weinmann-Menke
Recruiting
Gsk Investigational Site
Mainz, Germany
Andreas Schwarting
Recruiting
Gsk Investigational Site
Meerbusch, Germany
Stefan Vordenbaeumen
Recruiting

Greece

Gsk Investigational Site
Athens, Greece
Petros Sfikakis
Recruiting
Gsk Investigational Site
Athens, Greece
Pinelopi Konstantopoulou
Recruiting
Gsk Investigational Site
Athens, Greece
Dimitrios Boumpas
Recruiting
Gsk Investigational Site
Heraklion, Greece
George Bertsias
Recruiting
Gsk Investigational Site
Thessaloniki, Greece
Theodoros Dimitroulas
Recruiting

Italy

Gsk Investigational Site
Brescia, Italy
Micaela Fredi
Recruiting
Gsk Investigational Site
Ferrara, Italy
Marcello Govoni
Recruiting
Gsk Investigational Site
Milan, Italy
Lorenzo Dagna
Recruiting

74 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Jun 2024
Primary completion: 31 May 2027
Completion: 29 May 2029
Last update posted: 3 Jun 2026
Registered enrollment: 350
Registry id: NCT06411249

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-509146-35

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.